Deferoxamine Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-599

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferoxamine (NDC 63323-599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferoxamine Structure

FDA Label Image

Logo (Fk17 Address)

FDA Label Image

Pbox (Pbox)

Pbox (Pbox)
Deferoxamine Mesylate for Injection, USP is a medication available in a vial containing 500 mg. It can be administered subcutaneously, intramuscularly, or intravenously. Unfortunately, there is some unreadable text in the description.*
FDA Label Image

Pbox (Pbox2)

Pbox (Pbox2)
Deferoxamine Mesylate for Injection is a medication that comes in vials of 2 grams each. It can be administered by subcutaneous, intramuscular, or intravenous route. The vials are for single-use only and are manufactured by KABI.*
FDA Label Image

Vial (Vial)

Vial (Vial)
Deferoxamine Mesylate for Injection, USP is a medication available in vials containing 500mg for administration through subcutaneous, intramuscular or intravenous routes.*
FDA Label Image

Vial (Vial2)

Vial (Vial2)
Deferoxamine Mesylate is a medication available in the form of injections with 2 grams per vial. It can be administered subcutaneously, intramuscularly, or intravenously for medical purposes. The product is designed for single-use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.